Dr. Reddy’s announces USFDA acceptance to review its Biologics License Application (BLA) for proposed interchangeable biosimilar, Abatacept.
Electra announces a major milestone with the successful validation of its EVE‑Ai™ Adaptive Controls platform, enabling ...
The Automist home sprinkler system uses compact mist portals to put out flames while sparing important materials. We've never seen anything like it before.
I tested the Momcozy M5 wearable breast pump following the birth of my twins and found it comfortable and effective. See how ...
OpenAI's EVMbench tests AI on smart contract security. Claude Opus 4.6 ranked first, beating GPT-5 and Gemini 3 Pro across 120 real crypto vulnerabilities.
OpenAI, along with Paradigm and Ottersec, has released the EVMbench research paper, looking at how well different AI models ...
Cryptopolitan on MSN
AI agents review smart contracts to identify and fix security issues that lead to crypto losses
AI agents are now being tested against real smart contract vulnerabilities after $3.4 billion was lost to crypto hacks in 2025 ...
The worldwide shift to renewable energy creates strong demand for Energy Storage Systems (ESS) in grid support, industrial uses, and home areas. Battery technologies advance steadily. The protective ...
Myers' upcoming $30B patent cliff as the Growth portfolio lost significant potential. Read why BMY stock is downgraded to Hold.
In the drive towards smart cities and digital transformation, Bahrain’s facility managers face a common dilemma: what to do ...
Bristol Myers Squibb (NYSE:BMY) executives emphasized “focused execution” in 2025 and pointed to continued momentum entering 2026, as the company’s growth portfolio increasingly offsets declines in ...
AstraZeneca's full-year 2025 results are due on 10 February. Learn what investors should watch including Tagrisso sales, Farxiga growth and pipeline updates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results